Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Carolyn Lefkowits

Concepts (157)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genital Neoplasms, Female
20
2023
70
7.380
Why?
Cancer Pain
6
2019
20
3.050
Why?
Palliative Care
15
2023
641
3.010
Why?
Analgesics, Opioid
7
2021
771
2.160
Why?
Pain Management
5
2021
285
1.740
Why?
Medical Oncology
8
2022
229
1.550
Why?
Surgical Oncology
3
2019
18
1.430
Why?
Gynecology
7
2020
163
1.360
Why?
Hot Flashes
3
2013
72
1.200
Why?
Pain, Postoperative
3
2021
190
0.900
Why?
Referral and Consultation
4
2017
632
0.840
Why?
Hospice Care
2
2023
184
0.840
Why?
Terminal Care
3
2023
212
0.830
Why?
Opioid-Related Disorders
5
2019
413
0.760
Why?
Communication
3
2020
734
0.650
Why?
Practice Guidelines as Topic
2
2016
1381
0.590
Why?
Attitude of Health Personnel
3
2019
970
0.570
Why?
Neoplasms
2
2021
2086
0.540
Why?
Uterine Cervical Neoplasms
1
2019
213
0.540
Why?
Perinatal Care
1
2016
36
0.540
Why?
Palliative Medicine
1
2014
14
0.470
Why?
Obstetrics and Gynecology Department, Hospital
1
2014
3
0.460
Why?
Oncology Service, Hospital
1
2014
15
0.450
Why?
Ambulatory Care
2
2017
479
0.450
Why?
Female
30
2023
59324
0.450
Why?
Endometrial Neoplasms
3
2020
141
0.440
Why?
Cyclohexanecarboxylic Acids
1
2013
22
0.410
Why?
Cost of Illness
1
2014
254
0.410
Why?
Amines
1
2013
34
0.410
Why?
Needs Assessment
1
2014
315
0.400
Why?
Oncologists
3
2022
30
0.400
Why?
Complementary Therapies
1
2013
74
0.390
Why?
gamma-Aminobutyric Acid
1
2013
144
0.390
Why?
Analgesics
1
2013
156
0.370
Why?
Quality of Life
6
2023
2343
0.370
Why?
Humans
33
2023
114045
0.360
Why?
Health Services Accessibility
1
2016
756
0.360
Why?
Education, Medical, Graduate
1
2014
366
0.350
Why?
Hospice and Palliative Care Nursing
2
2022
69
0.340
Why?
Middle Aged
16
2021
26605
0.340
Why?
Guideline Adherence
1
2014
489
0.340
Why?
Employment
2
2021
137
0.340
Why?
Prostatic Neoplasms
2
2013
913
0.320
Why?
Aged
12
2020
18969
0.310
Why?
Epidemics
2
2018
66
0.280
Why?
Advance Care Planning
2
2020
195
0.250
Why?
Breast Neoplasms
2
2013
1846
0.240
Why?
Adult
11
2021
30375
0.240
Why?
Aged, 80 and over
4
2020
6306
0.230
Why?
Medical Futility
1
2023
20
0.220
Why?
Patient Care Team
2
2019
517
0.220
Why?
Gynecologic Surgical Procedures
2
2020
44
0.210
Why?
Neoplasm Recurrence, Local
2
2019
850
0.200
Why?
Retrospective Studies
7
2022
12521
0.200
Why?
Antineoplastic Agents, Hormonal
2
2013
138
0.190
Why?
Cohort Studies
4
2021
4883
0.190
Why?
Brachytherapy
2
2019
100
0.180
Why?
Ethics, Medical
1
2020
69
0.170
Why?
Enoxaparin
1
2020
52
0.170
Why?
Radiosurgery
1
2022
299
0.170
Why?
Young Adult
5
2020
10444
0.160
Why?
Pyridones
1
2020
122
0.160
Why?
Infection Control
1
2020
132
0.160
Why?
Carcinoma, Endometrioid
1
2019
46
0.160
Why?
Hospices
1
2020
83
0.160
Why?
Carcinosarcoma
1
2018
17
0.150
Why?
Postoperative Care
1
2020
223
0.150
Why?
Uterine Neoplasms
1
2018
73
0.150
Why?
Disease-Free Survival
1
2019
618
0.150
Why?
Drug Prescriptions
1
2019
237
0.140
Why?
Preoperative Care
1
2019
319
0.140
Why?
beta Catenin
1
2019
218
0.140
Why?
Pyrazoles
1
2020
361
0.140
Why?
Databases, Factual
2
2019
1125
0.140
Why?
Cancer Care Facilities
1
2017
29
0.140
Why?
Cancer Survivors
1
2020
205
0.140
Why?
Perinatal Death
1
2016
22
0.140
Why?
Venous Thromboembolism
1
2020
230
0.140
Why?
Survival Analysis
1
2020
1206
0.140
Why?
Drug and Narcotic Control
1
2016
29
0.140
Why?
Truth Disclosure
1
2016
39
0.130
Why?
Life Expectancy
1
2016
46
0.130
Why?
Nausea
1
2016
99
0.130
Why?
Anticoagulants
1
2020
547
0.130
Why?
Mood Disorders
1
2016
112
0.130
Why?
Self Efficacy
1
2019
353
0.130
Why?
Hospitalization
2
2014
1762
0.130
Why?
Pneumonia, Viral
1
2020
334
0.120
Why?
Coronavirus Infections
1
2020
326
0.120
Why?
Brain Neoplasms
1
2022
966
0.120
Why?
Outpatients
2
2017
325
0.120
Why?
Program Evaluation
1
2019
820
0.120
Why?
Physician-Patient Relations
1
2019
459
0.120
Why?
Patient Education as Topic
1
2019
666
0.120
Why?
Evidence-Based Medicine
1
2018
662
0.110
Why?
Mass Screening
1
2020
979
0.110
Why?
Stellate Ganglion
1
2013
4
0.110
Why?
Societies, Medical
1
2016
655
0.110
Why?
Anxiety
1
2019
843
0.110
Why?
Clonidine
1
2013
22
0.100
Why?
Symptom Assessment
1
2014
119
0.100
Why?
Ovariectomy
1
2013
116
0.100
Why?
Pandemics
1
2020
1310
0.100
Why?
Nerve Block
1
2013
60
0.100
Why?
Hormone Replacement Therapy
1
2013
76
0.100
Why?
Tamoxifen
1
2013
190
0.100
Why?
Ovarian Neoplasms
1
2016
386
0.100
Why?
Fellowships and Scholarships
1
2014
224
0.100
Why?
Continuity of Patient Care
1
2014
252
0.090
Why?
Drug Interactions
1
2013
337
0.090
Why?
Depression
1
2019
1133
0.090
Why?
Pain
1
2016
701
0.090
Why?
Data Collection
1
2014
618
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
1356
0.090
Why?
Multivariate Analysis
1
2014
1422
0.090
Why?
Follow-Up Studies
2
2018
4392
0.090
Why?
Adolescent
4
2020
17800
0.090
Why?
Colorado
1
2019
4090
0.080
Why?
Postoperative Complications
1
2020
2122
0.080
Why?
Quality Improvement
1
2016
944
0.080
Why?
Logistic Models
1
2014
1829
0.080
Why?
Chemoradiotherapy
2
2020
187
0.080
Why?
Curriculum
1
2014
813
0.080
Why?
Radiotherapy, Adjuvant
2
2019
182
0.070
Why?
United States
3
2020
12137
0.070
Why?
Surveys and Questionnaires
1
2019
4595
0.070
Why?
Severity of Illness Index
1
2014
2537
0.070
Why?
Infant, Newborn
1
2016
5038
0.070
Why?
Neoplasm Staging
2
2019
1162
0.060
Why?
Risk Factors
2
2019
8614
0.060
Why?
Case-Control Studies
2
2021
3003
0.050
Why?
Cranial Irradiation
1
2022
66
0.050
Why?
Unemployment
1
2020
39
0.040
Why?
Health Benefit Plans, Employee
1
2020
20
0.040
Why?
Resource Allocation
1
2020
37
0.040
Why?
Standard of Care
1
2020
62
0.040
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
31
0.040
Why?
DNA Polymerase II
1
2019
37
0.040
Why?
Microsatellite Instability
1
2019
32
0.040
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
76
0.040
Why?
Neoplasm Grading
1
2019
241
0.040
Why?
PTEN Phosphohydrolase
1
2019
140
0.040
Why?
SEER Program
1
2018
195
0.040
Why?
Chemotherapy, Adjuvant
1
2018
332
0.040
Why?
Male
2
2013
55396
0.040
Why?
Betacoronavirus
1
2020
247
0.040
Why?
Critical Care
1
2020
472
0.030
Why?
Tumor Suppressor Protein p53
1
2019
445
0.030
Why?
Prognosis
1
2022
3315
0.030
Why?
Randomized Controlled Trials as Topic
1
2019
1204
0.030
Why?
Membrane Proteins
1
2019
1016
0.030
Why?
Biomarkers, Tumor
1
2019
1032
0.030
Why?
Predictive Value of Tests
1
2017
1791
0.030
Why?
Mutation
1
2019
3338
0.020
Why?
Risk Assessment
1
2017
2958
0.020
Why?
Pregnancy
1
2020
5499
0.020
Why?
Prospective Studies
1
2017
6195
0.020
Why?
Lefkowits's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)